Accent Therapeutics

Translating extraordinary science into life-changing therapeutics for patients living with cancer

Business Model
B2B
Last Round
Series CJan 2024
Rounds
3

Indexed holds 3 funding rounds and 9 investors for this company. The full record is or through the API.

About

Accent Therapeutics takes a novel view of cancer by leveraging expertise in genomic instability and small-molecule drug discovery. The company looks beyond mutation-specific vulnerabilities to identify and exploit critical cellular dependencies that result from genomic and chromosomal instability observed across multiple cancer types. It develops small-molecule therapeutics designed to inhibit those targets, with programs that have the potential to benefit large patient populations with significant unmet medical need.

Summary

Accent Therapeutics is a Biotech company based in United States. Its most recent funding was a Series C round in Jan 2024. Investors include EcoR1 Capital, Mirae Asset and The Column Group.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJan 2024

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Accent Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/accent-therapeutics"><img src="https://indexed.vc/api/badge/company/accent-therapeutics" alt="Accent Therapeutics on Indexed.vc" width="260" height="76" /></a>